Home PR Jazz Wins ‘Most Recommended Company of 2025’ at Best Place to Work Awards
PR

Jazz Wins ‘Most Recommended Company of 2025’ at Best Place to Work Awards

Share
jazz-wins-most-recommended-company-of-2025-at-best-place-to-work-awards
Share

Jazz, Pakistan’s leading digital operator, has been recognised as the Most Recommended Company of 2025 at the Best Place to Work Pakistan Awards, organised by the Pakistan Society of Human Resource Management (PSHRM) and Engage Consulting.

Expressing her gratitude, Tazeen Shahid, Chief People Officer at Jazz, said: “This recognition is a reflection of our people — their trust, passion, and belief in what we stand for. At Jazz, we’re deeply committed to nurturing a culture where every individual can grow, belong, and make an impact. We’ll continue to invest in our people and in creating an environment where they can do their best work.”

The award adds to Jazz’s ongoing journey of building an inclusive and empowering workplace, with recent recognitions including the Most Inclusive Company at the GDEIB and Global DEI Benchmarks Awards 2025 and the IFC-PBC Employer of Choice Gender Diversity Award.

As Pakistan’s leading ServiceCo, Jazz remains committed to strengthening its culture, empowering its people, and shaping a workplace that continues to inspire.

Related Articles

ZARR Sets New Record as Azaadi Sale Momentum Accelerates

ZARR, JazzWorld’s leading fashion marketplace, has recorded its strongest-ever daily performance, marking...

Novo Nordisk appoints Mehtaz Sultan Khan as General Manager Pakistan

Novo Nordisk appoints Mehtaz Sultan Khan as General Manager Pakistan

Novo Nordisk, the global healthcare company with more than a century of...

Pakistan Influencer Awards

Pakistan Influencer Awards Set to Redefine Influence in the Country’s Creator Economy

The Pakistan Influencer Awards was officially launched in Karachi, marking the country’s...

ZYN

U.S. FDA authorizes 20 ZYN nicotine pouches to be marketed with specific modified risk claim in the United States of America

On June 30th the U.S. Food and Drug Administration (FDA) issued Modified...